ProShare Advisors’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $65.8K | Buy |
31,493
+6,106
| +24% | +$12.8K | ﹤0.01% | 1955 |
|
2025
Q1 | $43.3K | Sell |
25,387
-5,465
| -18% | -$9.32K | ﹤0.01% | 1966 |
|
2024
Q4 | $156K | Buy |
30,852
+7,188
| +30% | +$36.3K | ﹤0.01% | 1961 |
|
2024
Q3 | $129K | Buy |
23,664
+8,110
| +52% | +$44.1K | ﹤0.01% | 1844 |
|
2024
Q2 | $74.7K | Sell |
15,554
-2,708
| -15% | -$13K | ﹤0.01% | 1699 |
|
2024
Q1 | $56.8K | Buy |
18,262
+1,509
| +9% | +$4.69K | ﹤0.01% | 1889 |
|
2023
Q4 | $47.6K | Buy |
16,753
+2,036
| +14% | +$5.78K | ﹤0.01% | 1867 |
|
2023
Q3 | $43.1K | Buy |
14,717
+67
| +0.5% | +$196 | ﹤0.01% | 1727 |
|
2023
Q2 | $41.9K | Buy |
14,650
+582
| +4% | +$1.67K | ﹤0.01% | 1787 |
|
2023
Q1 | $43.5K | Sell |
14,068
-2,025
| -13% | -$6.26K | ﹤0.01% | 1683 |
|
2022
Q4 | $34K | Buy |
16,093
+5,483
| +52% | +$11.6K | ﹤0.01% | 1771 |
|
2022
Q3 | $34K | Buy |
10,610
+606
| +6% | +$1.94K | ﹤0.01% | 1690 |
|
2022
Q2 | $32K | Sell |
10,004
-656
| -6% | -$2.1K | ﹤0.01% | 1747 |
|
2022
Q1 | $75K | Sell |
10,660
-3,846
| -27% | -$27.1K | ﹤0.01% | 2076 |
|
2021
Q4 | $105K | Buy |
+14,506
| New | +$105K | ﹤0.01% | 2195 |
|